The impact factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
Withdrawal of drug therapy in responders to cardiac resynchronization therapy: rationale and design of the REMOVE trial
Francisco J. Pastor-PérezabIris P. Garrido-BravoabPablo Peñafiel-VerdúabNoelia Fernández-VillaabSergio Manzano-FernándezbcMaría José Oliva-SandovalbMaría Teresa Pérez-MartínezbCésar Caro-MartínezbÁlvaro Hernández-VicentecDomingo A. Pascual-Figalabcd
on behalf of the clinical trial REMOVE researches
a
Unidad de Insuficiencia Cardiaca y Trasplante, Hospital Clínico Universitario Virgen de la Arrixaca, El Palmar, Murcia, Spain
b
Servicio de Cardiología, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosantiaria (IMIB)-Pascual Parrilla, El Palmar Murcia, Spain
c
Departamento de Medicina Interna, Universidad de Murcia, Murcia, Spain
d
Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain
For the purchase of this article it is necessary to fill in the following form:
Customer service
Phone
Calls from Spain
932 415 960
Llamadas desde el extranjero
+34 932 415 960
Monday to Friday from 9am to 6pm (GMT+1) except for the months of July and August, which will be from 9am to 3pm.
E-mail
Are you a healthcare professional authorized to prescribe or dispense medications?